Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone

Liangliang Zhao; Majda Hadziahmetovic; Chenguang Wang; Xueying Xu; Ying Song; H. A. Jinnah; Jolanta Wodzinska; Jared Iacovelli; Natalie Wolkow; Predrag Krajacic; Alyssa Cwanger Weissberger; John Connelly; Michael Spino; Michael K. Lee; James Connor; Benoit Giasson; Z. Leah Harris; Joshua L. Dunaief

doi:10.1111/jnc.13292

Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone

Liangliang Zhao, Majda Hadziahmetovic, Chenguang Wang, Xueying Xu, Ying Song, H. A. Jinnah, Jolanta Wodzinska, Jared Iacovelli, Natalie Wolkow, Predrag Krajacic, Alyssa Cwanger Weissberger, John Connelly, Michael Spino, Michael K. Lee, James Connor, Benoit Giasson, Z. Leah Harris, Joshua L. Dunaief

Neuroscience

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons.

Original language	English (US)
Pages (from-to)	958-974
Number of pages	17
Journal	Journal of Neurochemistry
Volume	135
Issue number	5
DOIs	https://doi.org/10.1111/jnc.13292
State	Published - Dec 1 2015

Bibliographical note

Funding Information:
This work was funded by The Paul and Evanina Bell Mackall Foundation Trust, The F.M. Kirby Foundation, National Institutes of Health, (Grant/Award Number: ''NIH EY015240''). The Dunaief lab receives research funding from ApoPharma, Inc., and JLD is co-inventor on a patent pending for use of deferiprone for age-related macular degeneration. Michael Spino, John Connelly, and Jolanta Wodzinska are employees of ApoPharma. All experiments were conducted in compliance with the ARRIVE guidelines.

Publisher Copyright:
© 2015 International Society for Neurochemistry.

Keywords

ceruloplasmin/Hephaestin
deferiprone
glia
iron
neurodegeneration
oxidative stress

Access

10.1111/jnc.13292

Cite this

Zhao, L., Hadziahmetovic, M., Wang, C., Xu, X., Song, Y., Jinnah, H. A., Wodzinska, J., Iacovelli, J., Wolkow, N., Krajacic, P., Weissberger, A. C., Connelly, J., Spino, M., Lee, M. K., Connor, J., Giasson, B., Leah Harris, Z., & Dunaief, J. L. (2015). Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. Journal of Neurochemistry, 135(5), 958-974. https://doi.org/10.1111/jnc.13292

Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. / Zhao, Liangliang; Hadziahmetovic, Majda; Wang, Chenguang; Xu, Xueying; Song, Ying; Jinnah, H. A.; Wodzinska, Jolanta; Iacovelli, Jared; Wolkow, Natalie; Krajacic, Predrag; Weissberger, Alyssa Cwanger; Connelly, John; Spino, Michael; Lee, Michael K.; Connor, James; Giasson, Benoit; Leah Harris, Z.; Dunaief, Joshua L.

In: Journal of Neurochemistry, Vol. 135, No. 5, 01.12.2015, p. 958-974.

Research output: Contribution to journal › Article › peer-review

Zhao, L, Hadziahmetovic, M, Wang, C, Xu, X, Song, Y, Jinnah, HA, Wodzinska, J, Iacovelli, J, Wolkow, N, Krajacic, P, Weissberger, AC, Connelly, J, Spino, M, Lee, MK, Connor, J, Giasson, B, Leah Harris, Z & Dunaief, JL 2015, 'Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone', Journal of Neurochemistry, vol. 135, no. 5, pp. 958-974. https://doi.org/10.1111/jnc.13292

Zhao, Liangliang ; Hadziahmetovic, Majda ; Wang, Chenguang ; Xu, Xueying ; Song, Ying ; Jinnah, H. A. ; Wodzinska, Jolanta ; Iacovelli, Jared ; Wolkow, Natalie ; Krajacic, Predrag ; Weissberger, Alyssa Cwanger ; Connelly, John ; Spino, Michael ; Lee, Michael K. ; Connor, James ; Giasson, Benoit ; Leah Harris, Z. ; Dunaief, Joshua L. / Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. In: Journal of Neurochemistry. 2015 ; Vol. 135, No. 5. pp. 958-974.

@article{c09932efcca64f6c896e9844cfe45c90,

title = "Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone",

abstract = "Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons.",

keywords = "ceruloplasmin/Hephaestin, deferiprone, glia, iron, neurodegeneration, oxidative stress",

author = "Liangliang Zhao and Majda Hadziahmetovic and Chenguang Wang and Xueying Xu and Ying Song and Jinnah, {H. A.} and Jolanta Wodzinska and Jared Iacovelli and Natalie Wolkow and Predrag Krajacic and Weissberger, {Alyssa Cwanger} and John Connelly and Michael Spino and Lee, {Michael K.} and James Connor and Benoit Giasson and {Leah Harris}, Z. and Dunaief, {Joshua L.}",

note = "Funding Information: This work was funded by The Paul and Evanina Bell Mackall Foundation Trust, The F.M. Kirby Foundation, National Institutes of Health, (Grant/Award Number: ''NIH EY015240''). The Dunaief lab receives research funding from ApoPharma, Inc., and JLD is co-inventor on a patent pending for use of deferiprone for age-related macular degeneration. Michael Spino, John Connelly, and Jolanta Wodzinska are employees of ApoPharma. All experiments were conducted in compliance with the ARRIVE guidelines. Publisher Copyright: {\textcopyright} 2015 International Society for Neurochemistry.",

year = "2015",

month = dec,

day = "1",

doi = "10.1111/jnc.13292",

language = "English (US)",

volume = "135",

pages = "958--974",

journal = "Journal of Neurochemistry",

issn = "0022-3042",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone

AU - Zhao, Liangliang

AU - Hadziahmetovic, Majda

AU - Wang, Chenguang

AU - Xu, Xueying

AU - Song, Ying

AU - Jinnah, H. A.

AU - Wodzinska, Jolanta

AU - Iacovelli, Jared

AU - Wolkow, Natalie

AU - Krajacic, Predrag

AU - Weissberger, Alyssa Cwanger

AU - Connelly, John

AU - Spino, Michael

AU - Lee, Michael K.

AU - Connor, James

AU - Giasson, Benoit

AU - Leah Harris, Z.

AU - Dunaief, Joshua L.

N1 - Funding Information: This work was funded by The Paul and Evanina Bell Mackall Foundation Trust, The F.M. Kirby Foundation, National Institutes of Health, (Grant/Award Number: ''NIH EY015240''). The Dunaief lab receives research funding from ApoPharma, Inc., and JLD is co-inventor on a patent pending for use of deferiprone for age-related macular degeneration. Michael Spino, John Connelly, and Jolanta Wodzinska are employees of ApoPharma. All experiments were conducted in compliance with the ARRIVE guidelines. Publisher Copyright: © 2015 International Society for Neurochemistry.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons.

AB - Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons.

KW - ceruloplasmin/Hephaestin

KW - deferiprone

KW - glia

KW - iron

KW - neurodegeneration

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84954566898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954566898&partnerID=8YFLogxK

U2 - 10.1111/jnc.13292

DO - 10.1111/jnc.13292

M3 - Article

C2 - 26303407

AN - SCOPUS:84954566898

VL - 135

SP - 958

EP - 974

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -

Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone

Abstract

Bibliographical note

Keywords

Access

Other files and links

Fingerprint

Cite this